WHO: Nations mulling Gilead's COVID drug should consider trial flop, too
Health officials reviewing Gilead Science Inc's remdesivir against COVID-19 should consider all evidence, including a trial in which the medicine failed, before giving it the green light, the top WHO scientist said on Friday.
from bdnews24.com - Home https://ift.tt/37BQai9
from bdnews24.com - Home https://ift.tt/37BQai9
No comments